ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
121 hedge funds and large institutions have $164M invested in Achillion Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 40 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
58% less capital invested
Capital invested by funds: $394M → $164M (-$230M)
59% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 27
Holders
121
Holding in Top 10
1
Calls
$1.17M
Puts
$171K
Top Buyers
| 1 | +$5.16M | |
| 2 | +$3.66M | |
| 3 | +$2.09M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.09M |
| 5 |
Two Sigma Investments
New York
|
+$1.79M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$5.83M | |
| 3 | -$5.76M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.92M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$4.71M |